Related references
Note: Only part of the references are listed.Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass
Athanasios D. Anastasilakis et al.
BONE (2012)
Circulating γδ T cells and the risk of acute-phase response after zoledronic acid administration
Maurizio Rossini et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Transient changes in thyroid functions tests after zoledronic acid infusion
Helen Karga et al.
ENDOCRINE JOURNAL (2011)
The effects of recombinant human TSH on bone turnover in patients after thyroidectomy
Helen Karga et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2010)
Serum 25-Hydroxyvitamin D Levels Modulate the Acute-Phase Response Associated With the First Nitrogen-Containing Bisphosphonate Infusion
Francesco Bertoldo et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Characterization of and Risk Factors for the Acute-Phase Response after Zoledronic Acid
I. R. Reid et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Robert S. Weinstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Molecular mechanisms of action of bisphosphonates: Current status
Anke J. Roelofs et al.
CLINICAL CANCER RESEARCH (2006)
Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3
G Penna et al.
BLOOD (2005)
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gamma delta T cells in response to aminobisphosphonates is inhibited by statins
RE Hewitt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2005)
Fever after zoledronic acid administration is due to increase in TNF-α and IL-6
G Dicuonzo et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Share Paper
